4.2 Article Proceedings Paper

Revisiting progesterone receptor (PR) actions in breast cancer: Insights into PR repressive functions

Journal

STEROIDS
Volume 133, Issue -, Pages 75-81

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.steroids.2017.12.015

Keywords

Progesterone receptor; Breast cancer; Repressive actions

Funding

  1. National Institute of Cancer
  2. National Agency of Scientific Promotion of Argentina (ANPCyT) [2015-1587, PID 2012-066, IDB/PICT 2012-668]
  3. Grant Fondation Nelia et Amadeo Barletta-Switzerland
  4. ANPCyT [IDB/PICT 2008-189, 2012-1017]
  5. CONICET [PIP 59]

Ask authors/readers for more resources

Progesterone receptor (PR) is a master regulator in female reproductive tissues that controls developmental processes and proliferation and differentiation during the reproductive cycle and pregnancy. PR also plays a role in progression of endocrine-dependent breast cancer. As a member of the nuclear receptor family of ligand-dependent transcription factors, the main action of PR is to regulate networks of target gene expression in response to binding its cognate steroid hormone, progesterone. Liganded-PR transcriptional activation has been thoroughly studied and associated mechanisms have been described while progesterone-mediated repression has remained less explored. The present work summarizes recent advances in the understanding of how PR-mediated repression is accomplished in breast cancer cells and highlights the significance of fully understanding the determinants of context-dependent PR action.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available